Jacobs Levy Equity Management, Inc Terns Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $24.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.83 - $6.7 $156,278 - $369,987
-55,222 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$5.65 - $10.73 $182,562 - $346,707
-32,312 Reduced 36.91%
55,222 $390,000
Q3 2021

Nov 15, 2021
BUY
$7.22 - $13.46 $504,562 - $940,638
69,884 Added 395.94%
87,534 $912,000
Q2 2021

Aug 16, 2021
BUY
$12.26 - $22.0 $216,389 - $388,300
17,650 New
17,650 $216,000

Others Institutions Holding TERN

# of Institutions
168
Shares Held
78.3M
Call Options Held
580K
Put Options Held
454K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $191M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email